logo
The changes coming to European hand-luggage rules

The changes coming to European hand-luggage rules

CNNa day ago
In travel news this week: Why Thailand did a U-turn on legalizing marijuana, why the party might be over for Germany's clubbing capital, plus more generous luggage rules are coming to European flights.
European lawmakers have voted to get rid of tricksy, confusing airline carry-on fees and promote standardization across the industry.
The proposal still requires approval from EU member states but, if adopted, travelers could soon be guaranteed a lot more free hand luggage than is currently standard on the region's budget airlines.
Right now, low-cost carriers including EasyJet and Ryanair allow passengers one free bag that must fit under the seat in front.
However, with no standardized dimensions across airlines, travelers have often been caught unawares with incorrectly sized bags when switching between carriers.
The new rule would allow passengers to bring one cabin bag measuring up to 100 centimeters (about 40 inches) and weighing up to seven kilos (15.4 pounds), plus an under-the-seat personal item with maximum dimensions of 40 x 30 x 15 centimeters. (That's about the size of a small backpack.)
If it goes through, it will apply to all flights within the EU, as well as routes to and from the EU.
While this rule change has yet to be confirmed, there are other luggage changes already afoot.
Trade association Airlines for Europe (A4E), which represents 17 of the region's leading airlines, announced on Wednesday that its members have started applying the guaranteed set of dimensions of 40 × 30 × 15 centimeters for under-seat bags.
In line with this move, Ryanair, Europe's largest airline, has said that it will be increasing its small-item size limits from ​​40 x 25 x 20 centimeters to to 40 x 30 x 20 centimeters in 'the coming weeks, as our airport bag-sizers are adjusted.'
While doing those last-minute luggage checks before travel, it's not a bad idea to watch out for snakes — in Australia, at least.
A plane was delayed leaving Melbourne on Tuesday because one of the wriggly reptiles got loose in the hold. Watch here as snake catcher Mark Pelley got down to business.
Staff at Japan's Yamagata Airport had a bigger critter to contend with, when a bear on the runway forced flights to be canceled on June 26.
Traps set up near the runway failed to catch the furry trespasser, but airport officials said they would remain in place.
Magellanic penguins, named after the explorer Ferdinand Magellan, are native to Patagonia, but one little adventurer took to the seas like its famous namesake and was spotted swimming with beachgoers in Rio de Janeiro on June 29.
It wasn't the only industrious animal to hit the beach in June. A poodle is the newest member of a dog lifeguard team near Malaga in Spain.
Not all heroes wear capes — some have thick luxurious coats.
In 2022, Thailand became the first country in Asia to legalize marijuana. Just three years later, a dramatic government U-turn is set to rein in the country's 'green rush.'
Here's where things went wrong.
There will soon be a lot fewer clouds of smoke in France, too. The country has long been synonymous with cigarette culture, but it's now leading the way in Europe by banning smoking on beaches, in parks and in all outdoor areas frequented by children.
Rulebreakers face fines of up to 135 euros (around $150).
Next door in Germany, Berlin's reign as the hedonistic party capital of Europe might be coming to an end. The city's nightlife scene has been changing since the pandemic and now Gen Z wants a different kind of fun.
All this clean living requires an early start to the day. Our partners at CNN Underscored, a product reviews and recommendations guide owned by CNN, have this guide to the best alarm clocks of 2025.
Here's to being bright-eyed and bushy-tailed.
In the Montana town of Missoula, there's world-class wilderness in every direction. But there's much more to this eclectic university town than being a basecamp between two spectacular national parks (Yellowstone and Glacier, if you're asking).
There's amazing food, an outdoor music venue, fly fishing, and even surfing in the center of downtown.
The rivers are pretty famous too. The 1992 Brad Pitt movie 'A River Runs Through It,' helped put Missoula on the map.
'It just blew up at that point,' says local businessman Todd Frank, 'the number of people coming to recreate, we've been busy ever since then.'
She ditched New York for Paris at the age of 79.
She says it's the best decision she ever made.
This is not the seat you paid for.
Here's what to do if you get downgraded on a flight.
Two strangers met on a train.
Then they decided to travel the world together.
The best pizza in the United States?
Italy has the answer.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Google DeepMind has grand ambitions to ‘cure all diseases' with AI. Now, it's gearing up for its first human trials
Google DeepMind has grand ambitions to ‘cure all diseases' with AI. Now, it's gearing up for its first human trials

Yahoo

timean hour ago

  • Yahoo

Google DeepMind has grand ambitions to ‘cure all diseases' with AI. Now, it's gearing up for its first human trials

Alphabet's Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind's AlphaFold breakthrough, the company is pairing cutting-edge AI with pharma veterans to design medicines faster, cheaper, and more accurately. Alphabet's secretive drug discovery arm, Isomorphic Labs, is getting ready to start testing its AI-designed drugs in humans, Colin Murdoch, Isomorphic Labs president and Google DeepMind's chief business officer, told Fortune. 'There are people sitting in our office in King's Cross, London, working, and collaborating with AI to design drugs for cancer,' Murdoch said during an interview in Paris. 'That's happening right now.' After years in development, Murdoch says human clinical trials for Isomorphic's AI-assisted drugs are finally in sight. 'The next big milestone is actually going out to clinical trials, starting to put these things into human beings,' he said. 'We're staffing up now. We're getting very close.' The company, which was spun out of DeepMind in 2021, was born from one of DeepMind's most celebrated breakthroughs, AlphaFold, an AI system capable of predicting protein structures with a high level of accuracy. Interactions of AlphaFold progressed from being able to accurately predict individual protein structures to modeling how proteins interact with other molecules like DNA and drugs. These leaps made it far more useful for drug discovery, helping researchers design medicines faster and more precisely, turning the tool into a launchpad for a much larger ambition. 'This was the inspiration for Isomorphic Labs,' Murdoch said of AlphaFold. 'It really demonstrates that we could do something very foundational in AI that could help unlock drug discovery.' In 2024, the same year it released AlphaFold 3, Isomorphic signed major research collaborations with pharma companies Novartis and Eli Lilly. A year later, in April 2025, Isomorphic Labs raised $600 million in its first-ever external funding round, led by Thrive Capital. The deals are part of Isomorphic's plan to build a 'world-class drug design engine,' a system that combines machine learning researchers with pharma veterans to design new medicines faster, more cheaply, and with a higher chance of success. As part of the deals with major pharma players, Isomorphic supports existing drug programs, but it also designs its own internal drug candidates in areas such as oncology and immunology, with the aim of eventually licensing them out after early-stage trials. 'We identify an unmet need, and we start our own drug design programs. We develop those, put them into human clinical trials… we haven't got that yet, but we're making good progress,' he said. Today, pharma companies often spend millions attempting to bring a single drug to market, sometimes with just a 10% chance of success once trials begin. Murdoch believes Isomorphic's tech could radically improve those odds. 'We're trying to do all these things: speed them up, reduce the cost, but also really improve the chance that we can be successful,' he says. He wants to harness AlphaFold's technology to get to a point where researchers have 100% conviction that the drugs they are developing are going to work in human trials. 'One day we hope to be able to say — well, here's a disease, and then click a button and out pops the design for a drug to address that disease,' Murdoch said. 'All powered by these amazing AI tools.' This story was originally featured on

Chart of the Week: Wall Street Has Claimed Bitcoin—Now What?
Chart of the Week: Wall Street Has Claimed Bitcoin—Now What?

Yahoo

timean hour ago

  • Yahoo

Chart of the Week: Wall Street Has Claimed Bitcoin—Now What?

"Wall Street is coming for bitcoin." That phrase used to spark both hope and fear across crypto circles. Today, it's no longer a future threat or a bullish promise—it's just reality. The original premise of bitcoin (or crypto in general)—an asset that is censorship-resistant and doesn't answer to any traditional financial institution or government—is fading fast as Wall Street giants (as well as powerful political figures) continue to establish their strong foothold in the digital assets space. During the early years of the digital assets revolution, bitcoin was celebrated as uncorrelated and unapologetically anti-establishment. TradFi asset classes like S&P 500 would rise and fall—bitcoin didn't care. What bitcoin did care about were the flaws in the traditional financial system, which are still here to this day. A major example in BTC's history that's not-so-talked about anymore is the 2013 Cyprus banking crisis. The crisis, which occurred due to overexposure of banks to overleveraged local property companies and amid Europe's debt crisis, saw deposits above 100,000 euros get a substantial haircut. In fact, 47.5% of uninsured deposits were seized. Bitcoin's response was to move sharply upward to, for the first time in its history, cross the $1,000 threshold. After a prolonged bear market over the collapse of Mt. Gox, the idea of mass adoption grew, with Wall Street's entry into the sector seen as a stamp of validation for bitcoin as it meant more liquidity, mass adoption and price maturity. That changed everything. The price might have matured, as evidenced by waning volatility. But let's face it—bitcoin is now just another macro-driven risk asset. "Bitcoin, once celebrated for its low correlation to mainstream financial assets, has increasingly exhibited sensitivity to the same variables that drive equity markets over short time frames," said NYDIC Research in a report. In fact, the correlation is now hovering near the higher end of the historical range, according to NYDIG's calculations. "Bitcoin's correlation with U.S. equities remained elevated through the end of the quarter, closing at 0.48, a level near the higher end of its historical range." Simply put, when there is blood on the street (Wall Street that is), bitcoin bleeds too. When Wall Street sneezes, bitcoin catches a cold. Even bitcoin's 'digital gold' moniker is under pressure. NYDIG notes that bitcoin's correlation to physical gold and the U.S. dollar is near zero. So much for the 'hedge' argument—at least for now. So why the shift? The answer is simple: to Wall Street, bitcoin is just another risk asset, not digital gold, which is synonymous with "safe haven." Investors are repricing everything from central bank policy whiplash to geopolitical tension—digital assets included. "This persistent correlation strength with U.S. equities can largely be attributed to a series of macroeconomic and geopolitical developments, the tariff turmoil and the rising number of global conflicts, which significantly influenced investor sentiment and asset repricing across markets," said NYDIG. And like it or not, this is here to stay—at least for a short to medium-term. As long as central bank policy, macro, and war-linked red headlines hit the tape, bitcoin will likely move in tandem with equities. "The current correlation regime may persist as long as global risk sentiment, central bank policy, and geopolitical flashpoints remain dominant market narratives," NYDIG's report said. For the maxis and long-term holders, the original vision hasn't changed. Bitcoin's limited supply, borderless access, and decentralized nature remain untouched. Just don't expect them to impact price action just yet. For now, the market sees bitcoin as just another stock ticker. Just balance your trade strategies accordingly. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Oil Market Heading For Surplus In 2025 On Latest OPEC+ Output Hike
Oil Market Heading For Surplus In 2025 On Latest OPEC+ Output Hike

Forbes

timean hour ago

  • Forbes

Oil Market Heading For Surplus In 2025 On Latest OPEC+ Output Hike

An oil storage facility in Groot-Ammers, The Netherlands. The global oil market is likely heading for a surplus this year following a higher than expected production hike by OPEC+ over the weekend. At their meeting on Saturday, eight members of OPEC+, a select group of Russia-led oil producers and the Organization of the Petroleum Exporting Countries (OPEC) spearheaded by Saudi Arabia, opted to raise collective production levels for August by another 548,000 barrels per day. Producers Saudi Arabia, Russia, Iraq, United Arab Emirates, Kuwait, Kazakhstan, Algeria, and Oman cited 'healthy oil market fundamentals and steady global economic outlook' as the reasons behind the move indicating their belief that the global oil market can absorb the additional supply. The move, which took the market by surprise, came after three consecutive output hikes of 411,000 bpd announced by OPEC+ in recent months. The series of hikes are part of the producers' group's attempt to unwind 2.2 million bpd of previously agreed cuts since 2022. The latest hike implies 1.92 million bpd or over 87% of those cuts have now been unwound. As in previous instances, OPEC+ said: 'The gradual increases may be paused or reversed subject to evolving market conditions. This flexibility will allow the group to continue to support oil market stability.' An Oil Market Surplus Is Imminent For all intents and purposes, the volume of the hike is an oversized one demonstrative of OPEC's intention of putting more barrels on the market for a greater market share. The hope is that summer demand in the Northern hemisphere would absorb the additional barrels. However, the only issue that non-OPEC production is up at a record breaking pace led by the U.S., currently the world's largest oil producer. According to the Energy Information Administration - statistical arm of the U.S. Department of Energy - in April, the nation's crude production came in at an all-time high of 13.47 million bpd, breaking a previous record of 13.45 million bpd set in October 2024. The ranks of non-OPEC producers are also being boosted by higher output from Brazil, Canada, Guyana and Norway. Collectively, non-OPEC production growth is likely to rise by 1.4 million bpd, according to the International Energy Agency. Notwithstanding any additional OPEC+ barrels, such levels of non-OPEC growth alone are more than sufficient to account for global demand growth projections for this year that have been put forward by various forecasters. These range from 0.72 million bpd to 1.3 million bpd, with IEA and OPEC being at the opposite ends of that range. With additional barrels flowing in from all corners, there are fears the oil market may end up with a surplus of as much as 500,000 to 600,000 bpd, perhaps even more. As it becomes pretty apparent that OPEC+ now wants to take the fight to non-OPEC producers in a bid for market share, oil prices will likely head lower. Back in May, prior to the escalation of tensions in the Middle East the following month, Goldman Sachs was predicting sub-$60 average oil prices - $56 for Brent and $52 for U.S. benchmark West Texas Intermediate - as they head lower in the second half of the year. It was part of a rising number of its peers lining up to trim their price predictions for 2025-26 down to the $60s or below. Barring a major geopolitical escalation or macroeconomic event, OPEC+ has brought that world a lot closer with its latest hike.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store